Early-Stage Resectable NSCLC: A Shifting Landscape With Targeted Therapies and Immunotherapy [Video]

The perioperative therapeutic landscape for early-stage resectable NSCLC is advancing rapidly. Are you up to date?

Credit available for this activity expires: 22/11/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998570?ecd=bdc_podcast_libsyn_mscpedu